CD40·FasL and CTLA-4·FasL fusion proteins induce apoptosis in malignant cell lines by dual signaling

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 3159-3168

  Orbach, Ariel ^a   Rachmilewitz, Jacob ^a   Shani, Noam ^b   Isenberg, Yonatan ^a   Parnas, Miriam ^a   Huang, Jui Han ^c   Tykocinski, Mark L ^d   Dranitzki Elhalel, Michal ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b KAHR Medical Ltd   (Israel)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CASPASE 3; CASPASE 8; CASPASE 9; CD40 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; HYBRID PROTEIN;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER CELL; CELL KILLING; CELL PROLIFERATION; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 78650214751     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100301     Document Type: Article

References (58)

1. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995, 268:1347-1349
2. Martin SJ, Green DR: Protease activation during apoptosis: death by a thousand cuts? Cell 1995, 82:349-352
3. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P: A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 1997, 186:785-793 (Pubitemid 27381543)
4. Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T: Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 1996, 229:21-26
5. Clodi K, Snell V, Zhao S, Cabanillas F, Andreeff M, Younes A: Unbalanced expression of Fas and CD40 in mantle cell lymphoma. Br J Haematol 1998, 103:217-219
6. Castillo R, Mascarenhas J, Telford W, Chadburn A, Friedman SM, Schattner EJ: Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4. Leukemia 2000, 14:292-298 (Pubitemid 30095385)
7. Andersen NS, Larsen JK, Christiansen J, Pedersen LB, Christophersen NS, Geisler CH, Jurlander J: Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures. Blood 2000, 96:2219-2225
8. Visser HP, Tewis M, Willemze R, Kluin-Nelemans JC: Mantle cell lymphoma proliferates upon IL-10 in the CD40 system. Leukemia 2000, 14:1483-1489
9. Planken EV, Dijkstra NH, Willemze R, Kluin-Nelemans JC: Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the "CD40 system." Leukemia 1996, 10:488-493
10. Johnson PW, Watt SM, Betts DR, Davies D, Jordan S, Norton AJ, Lister TA: Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 1993, 82:1848-1857
11. Ghia P, Boussiotis VA, Schultze JL, Cardoso AA, Dorfman DM, Gribben JG, Freedman AS, Nadler LM: Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 1998, 91:244-251 (Pubitemid 28018751)
12. Greiner A, Knorr C, Qin Y, Schultz A, Marx A, Kroczek RA, Muller-Hermelink HK: CD40 ligand and autoantigen are involved in the pathogenesis of low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Dev Immunol 1998, 6:187-195
13. Romano MF, Lamberti A, Tassone P, Alfinito F, Costantini S, Chiurazzi F, Defrance T, Bonelli P, Tuccillo F, Turco MC, Venuta S: Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 1998, 92:990-995
14. Kitada S, Zapata JM, Andreeff M, Reed JC: Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia. Br J Haematol 1999, 106:995-1004
15. Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M, Montagna L, Piccoli P, Chilosi M, Caligaris-Cappio F: Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 2001, 97:2777-2783
16. Lomo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB: Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood 1997, 89:4415-4424 (Pubitemid 27260252)
17. Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ, Cesarman E: NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 2006, 107:3295-3302
18. Fiumara P, Younes A: CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies. Br J Haematol 2001, 113:265-274
19. Pham LV, Tamayo AT, Yoshimura LC, Lo P, Terry N, Reid PS, Ford RJ: A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas. Immunity 2002, 16:37-50
20. Younes A: The dynamics of life and death of malignant lymphocytes. Curr Opin Oncol 1999, 11:364-369
21. Storz M, Zepter K, Kamarashev J, Dummer R, Burg G, Haffner AC: Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides). Cancer Res 2001, 61:452-454 (Pubitemid 32128595)
22. Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M, Restivo VA Jr, Ke X, Gray GS, Nadler G, Nadler LM. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 1995, 92:811-815
23. Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN: Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem 2002, 277:7766-7775
24. Widney D, Boscardin WJ, Kasravi A, Martinez-Maza O: Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin's lymphoma cell lines. Tumour Biol 2003, 24:82-93
25. Huang JH, Tykocinski ML: CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells. Int Immunol 2001, 13:529-539
26. Dranitzki-Elhalel M, Huang JH, Sasson M, Rachmilewitz J, Parnas M, Tykocinski ML: CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism. Int Immunol 2007, 19:355-363 (Pubitemid 46523384)
27. Orbach A, Rachmilewitz J, Parnas M, Huang JH, Tykocinski ML, Dranitzki-Elhalel M: CTLA-4. FasL induces early apoptosis of activated T cells by interfering with anti-apoptotic signals. J Immunol 2007, 179:7287-7294
28. Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL: Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 1993, 177:845-850
29. Podojil JR, Kohm AP, Miller SD: CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis. J Immunol 2006, 177:2948-2958
30. Elhalel MD, Huang JH, Schmidt W, Rachmilewitz J, Tykocinski ML: CTLA-4. FasL induces alloantigen-specific hyporesponsiveness. J Immunol 2003, 170:5842-5850
31. Dranitzki-Elhalel M, Huang JH, Rachmilewitz J, Pappo O, Parnas M, Schmidt W, Tykocinski ML: CTLA-4.FasL inhibits allogeneic responses in vivo. Cell Immunol 2006, 239:129-135 (Pubitemid 44037545)
32. Cayabyab M, Phillips JH, Lanier LL: CD40 preferentially costimulates activation of CD4+ T lymphocytes. J Immunol 1994, 152:1523-1531
33. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998, 393:478-480 (Pubitemid 128728268)
34. Brenner B, Koppenhoefer U, Grassme H, Kun J, Lang F, Gulbins E: Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett 1997, 417:301-306
35. Brenner B, Koppenhoefer U, Lepple-Wienhues A, Grassme H, Muller C, Speer CP, Lang F, Gulbins E: The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation. Biochem Biophys Res Commun 1997, 239:11-17
36. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997, 386:517-521
37. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM: I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 1997, 272:17255-17257 (Pubitemid 27311147)
38. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J: Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195
39. Kirchhoff S, Muller WW, Krueger A, Schmitz I, Krammer PH: TCR-mediated up-regulation of c-FLIP short correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J Immunol 2000, 165:6293-6300
40. Schmitz I, Weyd H, Krueger A, Baumann S, Fas SC, Krammer PH, Kirchhoff S: Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J Immunol 2004, 172:2194-2200
41. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 1997, 326(Pt 1):1-16
42. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490 (Pubitemid 28391864)
43. Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501
44. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998, 281:1305-1308
45. Kruidering M, Evan GI: Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life 2000, 50:85-90
46. Krueger A, Baumann S, Krammer PH, Kirchhoff S: FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol 2001, 21:8247-8254
47. Thome M, Tschopp J: Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 2001, 1:50-58
48. Scaffidi C, Schmitz I, Krammer PH, Peter ME: The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999, 274:1541-1548 (Pubitemid 129507745)
49. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S: Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 2001, 276:20633-20640
50. Medema JP, de Jong J, van Hall T, Melief CJ, Offringa R: Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J Exp Med 1999, 190:1033-1038
51. Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A: The inhibitor of death receptor signaling: FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 1999, 190:1025-1032 (Pubitemid 29480831)
52. Sharp DA, Lawrence DA, Ashkenazi A: Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem 2005, 280:19401-19409
53. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J: The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 2000, 10:640-648
54. Golks A, Brenner D, Krammer PH, Lavrik IN: The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J Exp Med 2006, 203:1295-1305
55. Hu WH, Johnson H, Shu HB: Activation of NF-kappaB by FADD, Casper, and caspase-8. J Biol Chem 2000, 275:10838-10844
56. Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L: Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 2000, 19:4451-4460
57. Blair PJ, Riley JL, Harlan DM, Abe R, Tadaki DK, Hoffmann SC, White L, Francomano T, Perfetto SJ, Kirk AD, June CH: CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J Exp Med 2000, 191:651-660
58. Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G, Lamy T, Fest T, Tarte K, Guillaudeux T: CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL. J Immunol 2008, 181:1001-1011